{"id":"W4415937477","doi":"10.1200/oa-25-00053","title":"Enfortumab Vedotin in Patients With Previously Treated Advanced Breast Cancer in the Phase II EV-202 Study","year":2025,"lang":"en","type":"article","venue":"JCO oncology advances.","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Rash; Maculopapular rash; Breast cancer; Adverse effect; Regimen; Clinical endpoint; Phases of clinical research; Toxicity; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008021279,0.000369341,0.000541891,0.0001141533,0.0001200239,0.0004436706,0.0003160661,0.000384035,0.001623244],"category_scores_gemma":[0.000404758,0.0001612485,0.0004132517,0.0001378388,0.0001999972,0.0003036315,0.0001562907,0.0008944925,0.0002904387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003379095,"about_ca_system_score_gemma":0.0005540124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003648101,"about_ca_topic_score_gemma":0.001411419,"domain_scores_codex":[0.9998603,0.00007332503,0.000006935012,0.00001652306,0.00001763771,0.00002525387],"domain_scores_gemma":[0.9998409,0.0000311903,0.00003670842,0.00001307951,0.00001162366,0.00006642746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4684055,0.04888506,0.0383078,0.002036482,0.001707483,0.0005379529,0.0002652665,0.005429692,0.06452242,0.001121843,0.008867134,0.3599134],"study_design_scores_gemma":[0.4472937,0.4704777,0.04061016,0.0002380953,0.000968362,0.0009838564,0.0001888996,0.004874329,0.01059584,0.0007364893,0.02299219,0.00004036808],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912305,0.004185755,0.0003260053,0.0002108742,0.00007640169,0.0008293017,0.0005314999,0.00004592996,0.002563668],"genre_scores_gemma":[0.9929978,0.002180452,0.0006611968,0.0005197152,0.00008206105,0.0006009647,0.001096726,0.00001105401,0.001849956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001623244,"threshold_uncertainty_score":0.005430281,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01476243486084391,"score_gpt":0.4208429098651232,"score_spread":0.4060804750042793,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}